Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN‐TIMI 36 Trial

ConclusionsIn patients with chronic angina, ranolazine reduced recurrent ischemic events, regardless of whether patients did or did not receive PCI within 30 days of a non‐ST‐segment ACS.

Source: Clinical Cardiology - May 1, 2015 Category: Cardiology Authors: Jorge A. Gutierrez, Ewa Karwatowska‐Prokopczuk, Sabina A. Murphy, Luiz Belardinelli, Ramin Farzaneh‐Far, Gennyne Walker, David A. Morrow, Benjamin M. Scirica Tags: Clinical Investigations Source Type: research